ATEC (Alphatec) Net Profit

Corporate emblem and logo of atecspine.com (ATEC)

Alphatec Holdings, Inc. (ATEC) specializes in developing high-tech implants for spinal surgery. The company's financial profit on this chart reflects revenue dynamics, where the -0.09 metric determines the parameter status. The business relies on a closed neuromonitoring ecosystem, optimized express delivery of instruments to clinics, and rapid revenue growth, which effectively offsets expansion costs and supports liquidity.

ATEC: Alphatec Holdings, Inc. Net Profit 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for Alphatec (ATEC)

- current quotes and average value forecast:
Market Chart Alphatec Corp|ATEC - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Alphatec Corp|ATEC - Total Company Value
- book capitalization data:
Net Assets per Single Share Alphatec|ATEC - Book Capitalization|Market Capitalization to Book Value atecspine.com|ATEC - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Alphatec Holdings, Inc.|ATEC - Long-Term Debt to Capital|Current Liabilities to Capital Alphatec Holdings|ATEC - Company Aggregate Debts|Debt to Book Value Ratio Alphatec Corp|ATEC - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Alphatec|Quick Liquidity Indicator atecspine.com
- earnings and valuation multiples information:
ATEC - Net Profit
Fundamental valuation:Alphatec Corp
Product sample of Alphatec Holdings, Inc.

The scaling of high-tech spinal surgery system implementation by Alphatec Holdings, Inc. (ATEC) directly determines the company's net income dynamics, which reflects the market consensus on actual business efficiency. Analyzing this indicator allows for an assessment of how innovative advantages and surgeon loyalty convert into actual cash flow, serving as the foundation for determining the asset's fundamental stability and fair value.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|AORT: Net Profit|Company Net Income Enovis Corp (ENOV)|IART (Integra) - Net Profit|Company Profit ESTA (Establishment Labs Inc)|Net Income BBNX (Beta Bionics Inc)|IRMD (iradimed.com) - Final Profit|Company Net Income Embecta EMBC|TNDM - Net Income|Axogen Corp - Net Profit|Company Net Income SI-BONE Medical|OFIX: Net Profit|Company Profit BVS|KIDS (OrthoPediatrics Corp) - Net Profit|Treace Medical Concepts Inc (TMCI) - Net Financial Result|Net Profit SRTA|Net Income Carlsmed Medical CARL|Net Profit RXST (RxSight, Inc.)|Net Profit ClearPoint Neuro Inc. CLPT|STXS - Company Net Income|STIM: Company Net Income|SGHT (Sight Sciences, Inc) - Net Income|Orchestra BioMed Inc. - Final Profit|ANIK (Anika Therapeutics Inc.) - Net Profit|Company Net Income inspiremd.com NSPR|Company Net Income Jin Medical International (ZJYL)|vivani.com (VANI) - Annual Net Income|Xtant Medical - Net Income|Net Profit NeuroOne Medical Technologies Corp. NMTC|Modular Med - Net Profit|Net Financial Result myomo.com MYO|Envoy Medical (COCH) - Company Net Income|Profit After Tax VVOS (Vivos Therapeutics Inc.)|Company Net Income enVVeno|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOL: Net Profit|Dynatronics (DYNT) - Net Profit|Company Net Income Paragon 28 Inc.|Company Net Income INVO